GABA type A receptor α1 binding and negative regulation of TLR4 leads to epilepsy–migraine comorbidity, and TLR4 is a key intermediate in epilepsy–migraine comorbidity (Lin et al., 2022). This evidence concerns the gene TLR4 and migraine disorder.